Cite
Single-dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants.
MLA
Devineni, Damayanthi, et al. “Single-Dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants.” Clinical Therapeutics, vol. 38, no. 1, Jan. 2016, p. 89. EBSCOhost, https://doi.org/10.1016/j.clinthera.2015.11.008.
APA
Devineni, D., Polidori, D., Curtin, C., Stieltjes, H., Tian, H., & Wajs, E. (2016). Single-dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants. Clinical Therapeutics, 38(1), 89. https://doi.org/10.1016/j.clinthera.2015.11.008
Chicago
Devineni, Damayanthi, David Polidori, Christopher Curtin, Hans Stieltjes, Hong Tian, and Ewa Wajs. 2016. “Single-Dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants.” Clinical Therapeutics 38 (1): 89. doi:10.1016/j.clinthera.2015.11.008.